BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9467570)

  • 1. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
    Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
    Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
    J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein.
    Iida K; Takahashi Y; Kaji H; Takahashi MO; Okimura Y; Nose O; Abe H; Chihara K
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1011-6. PubMed ID: 10084588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme elevation of serum growth hormone-binding protein concentrations resulting from a novel heterozygous splice site mutation of the growth hormone receptor gene.
    Aalbers AM; Chin D; Pratt KL; Little BM; Frank SJ; Hwa V; Rosenfeld RG
    Horm Res; 2009; 71(5):276-84. PubMed ID: 19339792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
    Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.
    Woods KA; Fraser NC; Postel-Vinay MC; Savage MO; Clark AJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1686-90. PubMed ID: 8626815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
    Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
    Amit T; Youdim MB; Hochberg Z
    J Clin Endocrinol Metab; 2000 Mar; 85(3):927-32. PubMed ID: 10720017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
    Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
    Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
    Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome.
    Kaji H; Nose O; Tajiri H; Takahashi Y; Iida K; Takahashi T; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3705-9. PubMed ID: 9360529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction.
    Milward A; Metherell L; Maamra M; Barahona MJ; Wilkinson IR; Camacho-Hübner C; Savage MO; Bidlingmaier M; Clark AJ; Ross RJ; Webb SM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1259-66. PubMed ID: 15001620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
    Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
    Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GH receptor and GH insensitivity.
    Ross RJ
    Growth Horm IGF Res; 1999 Jun; 9 Suppl B():42-5; discussion 45-6. PubMed ID: 10549305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I.
    Kang JH; Kim OS; Kim JH; Lee SK; Park YJ; Baik HW
    Int J Mol Med; 2012 Sep; 30(3):713-7. PubMed ID: 22751808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C422F mutation of the growth hormone receptor gene is not responsible for short stature.
    Iida K; Takahashi Y; Kaji H; Onodera N; Takahashi MO; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4214-9. PubMed ID: 10566675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.
    Pantel J; Grulich-Henn J; Bettendorf M; Strasburger CJ; Heinrich U; Amselem S
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1705-10. PubMed ID: 12679461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome.
    Freeth JS; Ayling RM; Whatmore AJ; Towner P; Price DA; Norman MR; Clayton PE
    Endocrinology; 1997 Jan; 138(1):55-61. PubMed ID: 8977385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.
    Goddard AD; Covello R; Luoh SM; Clackson T; Attie KM; Gesundheit N; Rundle AC; Wells JA; Carlsson LM
    N Engl J Med; 1995 Oct; 333(17):1093-8. PubMed ID: 7565946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.